
Your window to the world of the pharmaceutical industry - clinical trials and drug regulatory affairs
| Platform | Pricing | Only free issues | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 446 | Founded | 4 years ago | Last Issue | 8 days ago |
| Active | |||||

During a US Senate Committee hearing a couple days ago, Dr. Anthony Fauci, the prime architect of the devastating COVID “pandemic” response policies, refused to answer any questions about what he knew and when he knew it.
Millions died du...
With astounding and embarrassing revelations contained in the personal diary of Dr. Fauci during the recent US Congressional hearings on the COVID “pandemic”, the world now clearly understands the deception and lies perpetrated on the world...
Some of the world’s best evidence showing the Covid “vaccines” killed people (perhaps many millions worldwide) was uncovered by expert data analyst Mr. Barry Young in New Zealand.
Share
Working as a key Covid data analyst during the “pand...
One of the most important human rights case in the history of Australia is proceeding despite Queensland government desperate attempts to block this case from being heard.
I reproduce below the post of 22 July by Boom Finance and Economics...
No drug (or vaccine) is “safe”…..not a single one. This is a fact that all credible clinicians and pharmacologists understand. It is indisputable.
In Australia, the law had to be amended to permit the government claim that the COVID-19 “va...
Subscribers, engagement, traffic and sponsorship for Phillip Altman BPharm(Hons), MSc, PhD.
| Subscribers | Engagement | 82 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #63 |
The writers behind this newsletter.
Pharmacologist - Clinical Trial and Drug Regulatory Affairs senior industry pharmaceutical consultant in drug research and regulatory approval with more than 40 years experience. BPharm(Hons), MSc, PhD
You can find recent issues that have been published by Phillip Altman BPharm(Hons), MSc, PhD on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Phillip Altman BPharm(Hons), MSc, PhD, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Phillip Altman BPharm(Hons), MSc, PhD as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Phillip Altman BPharm(Hons), MSc, PhD using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Phillip Altman BPharm(Hons), MSc, PhD. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.